Stock listing
Dusseldorf:82P Pacira BioSciences, Inc. Aktie
German listing (Dusseldorf) of Pacira BioSciences, Inc. · home listing NASDAQ:PCRX
Follow Pacira BioSciences, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:PCRX
$36.40 USD +0.01 (+0.0%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PCRX
- Day range
- $36.38 – $36.41 USDNov 2, 2026
- Volume
- 810,925 sharesNov 2, 2026
- Market cap
- $1.45B USDAt the close on Nov 2, 2026 · price × 39.91M shares outstanding
- 52-week range
- $18.80 – $36.67 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $40.50M USDMedian day 628,500 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PCRX · Home | $36.40 USD | +0.01 (0.0%) | 810,925 | $36.40 | $36.41 | $36.38 | $36.39 | Close on Nov 2, 2026 |
| Frankfurt:82P | €32.20 EUR | 0.00 (0.0%) | — | €32.00 | €32.20 | €32.00 | €32.20 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:PCRX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $36.40 | +0.01 | 0.0% | $36.40 | $36.41 | $36.38 | 810,925 | |
| $36.39 | 0.00 | 0.0% | $36.40 | $36.43 | $36.38 | 737,023 | |
| $36.39 | 0.00 | 0.0% | $36.39 | $36.40 | $36.37 | 618,925 | |
| $36.39 | -0.01 | 0.0% | $36.38 | $36.40 | $36.35 | 913,998 | |
| $36.40 | +0.02 | +0.1% | $36.38 | $36.42 | $36.38 | 471,788 | |
| $36.38 | -0.04 | -0.1% | $36.38 | $36.45 | $36.37 | 606,696 | |
| $36.42 | +0.08 | +0.2% | $36.33 | $36.42 | $36.33 | 574,300 | |
| $36.34 | +0.01 | 0.0% | $36.38 | $36.40 | $36.31 | 1,051,000 | |
| $36.33 | -0.05 | -0.1% | $36.36 | $36.39 | $36.32 | 1,488,300 | |
| $36.38 | +0.04 | +0.1% | $36.39 | $36.43 | $36.33 | 1,048,400 | |
| $36.34 | 0.00 | 0.0% | $36.35 | $36.39 | $36.33 | 1,065,900 | |
| $36.34 | +0.01 | 0.0% | $36.38 | $36.39 | $36.32 | 960,900 | |
| $36.33 | -0.07 | -0.2% | $36.39 | $36.67 | $36.31 | 2,064,100 | |
| $36.40 | +0.09 | +0.2% | $36.33 | $36.48 | $36.31 | 2,331,800 | |
| $36.31 | -0.04 | -0.1% | $36.35 | $36.35 | $36.30 | 2,221,900 | |
| $36.35 | +0.04 | +0.1% | $36.34 | $36.35 | $36.32 | 2,007,400 | |
| $36.31 | -0.08 | -0.2% | $36.33 | $36.36 | $36.31 | 4,690,000 | |
| $36.39 | +11.19 | +44.4% | $36.33 | $36.46 | $36.27 | 28,900,300 | |
| $25.20 | +0.44 | +1.8% | $25.05 | $26.00 | $24.99 | 802,700 | |
| $24.76 | -0.29 | -1.2% | $25.13 | $25.25 | $24.56 | 493,100 | |
| $25.05 | -0.16 | -0.6% | $25.37 | $25.71 | $24.83 | 560,200 | |
| $25.21 | +0.20 | +0.8% | $25.04 | $25.66 | $24.66 | 469,800 | |
| $25.01 | -0.04 | -0.2% | $25.05 | $25.38 | $24.93 | 510,600 | |
| $25.05 | -0.60 | -2.3% | $25.59 | $25.77 | $24.91 | 628,500 | |
| $25.65 | +0.26 | +1.0% | $25.30 | $25.67 | $25.13 | 643,600 | |
| $25.39 | +0.27 | +1.1% | $25.15 | $25.76 | $24.79 | 478,800 | |
| $25.12 | -0.44 | -1.7% | $25.50 | $25.66 | $25.00 | 444,200 | |
| $25.56 | +0.93 | +3.8% | $24.58 | $25.60 | $24.50 | 725,100 | |
| $24.63 | -0.07 | -0.3% | $25.00 | $25.21 | $24.51 | 450,700 | |
| $24.70 | +0.59 | +2.4% | $24.36 | $24.97 | $24.20 | 380,500 | |
| $24.11 | -0.58 | -2.3% | $24.79 | $24.99 | $23.98 | 375,500 | |
| $24.69 | +0.21 | +0.9% | $24.36 | $24.72 | $24.20 | 680,900 | |
| $24.48 | -0.43 | -1.7% | $25.11 | $25.20 | $24.45 | 393,800 | |
| $24.91 | +0.83 | +3.4% | $24.06 | $24.91 | $24.06 | 759,100 | |
| $24.08 | -0.60 | -2.4% | $24.63 | $24.94 | $23.65 | 824,500 | |
| $24.68 | -0.68 | -2.7% | $25.71 | $25.99 | $24.65 | 417,700 | |
| $25.36 | +0.20 | +0.8% | $25.43 | $25.57 | $25.18 | 538,000 | |
| $25.16 | -0.72 | -2.8% | $25.92 | $26.00 | $25.10 | 733,800 | |
| $25.88 | +0.01 | 0.0% | $25.62 | $25.88 | $25.13 | 571,700 | |
| $25.87 | -0.48 | -1.8% | $25.98 | $26.41 | $25.68 | 386,400 | |
| $26.35 | -0.25 | -0.9% | $26.38 | $26.65 | $26.31 | 481,700 | |
| $26.60 | +0.02 | +0.1% | $26.74 | $26.84 | $26.32 | 598,500 | |
| $26.58 | +0.11 | +0.4% | $26.52 | $26.91 | $26.24 | 610,800 | |
| $26.47 | +0.57 | +2.2% | $26.01 | $26.50 | $25.98 | 729,500 | |
| $25.90 | +0.14 | +0.5% | $25.75 | $26.07 | $25.46 | 380,500 | |
| $25.76 | -0.07 | -0.3% | $25.74 | $26.05 | $25.56 | 483,600 | |
| $25.83 | -0.07 | -0.3% | $25.63 | $26.03 | $25.36 | 413,400 | |
| $25.90 | +0.37 | +1.4% | $25.46 | $26.03 | $25.32 | 506,100 | |
| $25.53 | +0.67 | +2.7% | $24.89 | $25.59 | $24.80 | 379,700 | |
| $24.86 | +0.19 | +0.8% | $24.60 | $25.04 | $24.49 | 336,700 | |
| $24.67 | +0.84 | +3.5% | $23.91 | $24.72 | $23.66 | 474,900 | |
| $23.83 | -0.53 | -2.2% | $24.11 | $24.41 | $23.72 | 402,800 | |
| $24.36 | +0.36 | +1.5% | $24.04 | $24.58 | $24.04 | 336,200 | |
| $24.00 | +0.76 | +3.3% | $23.32 | $24.05 | $23.32 | 443,600 | |
| $23.24 | +0.24 | +1.0% | $23.23 | $23.72 | $22.97 | 653,900 | |
| $23.00 | -0.18 | -0.8% | $23.21 | $23.37 | $22.79 | 645,100 | |
| $23.18 | -0.52 | -2.2% | $24.08 | $24.29 | $23.01 | 806,800 | |
| $23.70 | -0.68 | -2.8% | $24.38 | $24.54 | $23.52 | 758,800 | |
| $24.38 | -0.05 | -0.2% | $24.49 | $24.78 | $24.26 | 802,600 | |
| $24.43 | -0.59 | -2.4% | $24.74 | $25.25 | $24.24 | 728,700 | |
| $25.02 | -0.56 | -2.2% | $25.67 | $25.68 | $24.94 | 603,200 | |
| $25.58 | +0.71 | +2.9% | $24.90 | $25.72 | $24.70 | 820,100 | |
| $24.87 | -2.75 | -10.0% | $26.06 | $26.74 | $24.21 | 1,702,000 | |
| $27.62 | +0.70 | +2.6% | $26.68 | $27.66 | $26.37 | 1,130,100 | |
| $26.92 | +0.51 | +1.9% | $26.09 | $26.92 | $25.92 | 1,166,500 |
- Ticker
- Dusseldorf:82P
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Oct 8, 2026
Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies
Latest earnings call · Aug 4, 2026
Pacira Biosciences (NASDAQ:PCRX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Q2 2026 Earnings Presentation
Earnings · 16 slides
Calls
Replays
Pacira Biosciences (NASDAQ:PCRX) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 4:30 PM ET
Watch TranscriptPacira Biosciences (NASDAQ:PCRX) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 4:30 PM ET
Watch TranscriptPacira Biosciences (NASDAQ:PCRX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies
Oct 8, 2026
Closed $36.39 (+44.4%) on Oct 8, 2026
Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home
Oct 7, 2026
Closed $25.20 (+1.8%) on Oct 7, 2026
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
Oct 5, 2026
Closed $25.05 (-0.6%) on Oct 5, 2026
Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases
Aug 6, 2026
Closed $25.58 (+2.9%) on Aug 6, 2026
Pacira BioSciences Reports Second Quarter 2026 Financial Results
Aug 4, 2026
Closed $24.87 (-10.0%) on Aug 5, 2026
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America's Workforce
Jul 29, 2026
Closed $26.40 (-1.5%) on Jul 29, 2026
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
Jul 27, 2026
Closed $26.47 (+2.3%) on Jul 27, 2026
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
Jul 22, 2026
Closed $25.59 (-0.7%) on Jul 22, 2026
Pacira BioSciences Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
Jul 9, 2026
Closed $25.50 (-0.1%) on Jul 9, 2026
Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®
Jul 1, 2026
Closed $25.03 (-1.3%) on Jul 1, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 16 slides · August 2026
Technical Presentation (June 2026)
Technical · 13 slides · Jun 24, 2026
Proxy Contest (May 2026)
Proxy contest · 66 slides · May 20, 2026
Proxy Contest (May 2026)
Proxy contest · 22 slides · May 12, 2026
Pacira BioSciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 53 in the last 12 months · 250 in all · newest Oct 8, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 4, 2026
- Decks
- 17 decks · latest August 2026
Where Pacira BioSciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PCRX · Home listing | NASDAQ | United States | USD |
| Lang & Schwarz:A1H68T | Lang & Schwarz | Germany | EUR |
| Frankfurt:82P | Frankfurt | Germany | EUR |
| LS Exchange:A1H68T | LS Exchange | Germany | EUR |
| gettex:82P | gettex | Germany | EUR |
| BOATS:PCRX | BOATS | United States | USD |
| Munich:82P | Munich | Germany | EUR |
| Tradegate:82P | Tradegate | Germany | EUR |
| BX Swiss:82P | BX Swiss | Switzerland | CHF |
| Dusseldorf:82P · This page | Dusseldorf | Germany | EUR |
| Stuttgart:82P | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Pacira BioSciences, Inc.